Setting the Standard: Our CRO earns GLP Certification
We are delighted to announce that our Clinical Research Center has achieved certification for compliance with Good Laboratory Practice (GLP). This prestigious certification confirms that our laboratory operates according to ...
Pharmbiotest Poland attended BIOEurope 2024 in Stockholm
We were thrilled to take part in BIO-Europe 2024 in Stockholm! This year’s event gathered an impressive network of over 5,000 participants from 60 countries, providing our team with invaluable ...
Pharmbiotest Poland team participated in the Conference ” We! Are Clinical Research”!
We are thrilled to share that the Pharmbiotest Poland team participated in the 4th International Conference " We! Are Clinical Research"! It was an incredible opportunity to engage with leading ...
Pharmbiotest took part in the international congress in Rome
Pharmbiotest representatives took part in the congress of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT 2021) held in Rome at the end of September. IATDMCT is ...
Pharmbiotest visited the international exhibition in Milan
Pharmbiotest representatives had been invited and hence took part in the prestigious international pharmaceutical exhibition CPhI Worldwide 2021 in Milan, Italy The event has been visited by 1,400 companies from ...
PHARMBIOTEST supported drug manufacturers and did not discontinue clinical trials at the peak of the pandemics
Clinical and Diagnostic Center Pharmbiotest managed not to suspend the process of conducting clinical trials regardless the quarantine regime in Ukraine imposed because of corona virus SARS-CoV-2 last year. At ...